findmyKOL
Clinical trialNCT03592641TerminatedPhase 2Interventional

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

SponsorNational Cancer Institute (NCI)Enrollment5Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal AdenocarcinomaStage III Colon Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIIA Colon Cancer AJCC v8+15 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Los Angeles County-Usc Medical Center

    Los Angeles, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, United States

  • Smilow Cancer Hospital-Derby Care Center

    Derby, Connecticut, United States

  • Smilow Cancer Hospital Care Center-Fairfield

    Fairfield, Connecticut, United States

  • Smilow Cancer Hospital Care Center - Guilford

    Guilford, Connecticut, United States

  • Smilow Cancer Hospital Care Center at Saint Francis

    Hartford, Connecticut, United States

  • Smilow Cancer Center/yale-New Haven Hospital

    New Haven, Connecticut, United States

  • Yale University

    New Haven, Connecticut, United States

  • Yale-New Haven Hospital North Haven Medical Center

    North Haven, Connecticut, United States

  • Smilow Cancer Hospital-Orange Care Center

    Orange, Connecticut, United States

  • Smilow Cancer Hospital-Torrington Care Center

    Torrington, Connecticut, United States

  • Smilow Cancer Hospital Care Center-Trumbull

    Trumbull, Connecticut, United States

  • Smilow Cancer Hospital-Waterbury Care Center

    Waterbury, Connecticut, United States

  • Smilow Cancer Hospital Care Center - Waterford

    Waterford, Connecticut, United States

  • University of Florida Health Science Center - Gainesville

    Gainesville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • University of Kansas Clinical Research Center

    Fairway, Kansas, United States

  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

  • University of Kansas Hospital-Westwood Cancer Center

    Westwood, Kansas, United States

  • University of Kentucky/markey Cancer Center

    Lexington, Kentucky, United States

  • Siteman Cancer Center at Saint Peters Hospital

    City of Saint Peters, Missouri, United States

  • Siteman Cancer Center at West County Hospital

    Creve Coeur, Missouri, United States

  • Siteman Cancer Center at Christian Hospital

    St Louis, Missouri, United States

  • Siteman Cancer Center-South County

    St Louis, Missouri, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Nyu Winthrop Hospital

    Mineola, New York, United States

  • Bellevue Hospital Center

    New York, New York, United States

  • Laura and Isaac Perlmutter Cancer Center at Nyu Langone

    New York, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Parkland Memorial Hospital

    Dallas, Texas, United States

  • Ut Southwestern/simmons Cancer Center-Dallas

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jul 2019
Primary completion
31 Jul 2021
Completion
30 Dec 2021
Last update posted
17 Oct 2023
Registered enrollment
5
Registry id
NCT03592641

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.